PreprintAll rights reservedmedRxiv
Effect of Vesicular Monoamine Transporter Type-2 Inhibitors on Motor Features in HD
- 1University of Iowa Hospitals and Clinics
Related
- Design, synthesis, and biological evaluation of naphthalimide derivatives as dual monoamine oxidase-B and amyloid-β aggregation inhibitors for Alzheimer's disease.
- Sirtuin 1 modulation unlocks the therapeutic potential of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in calcific aortic valve stenosis
- Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL‐2 Inhibitors
- Impaired cerebrovascular-cerebrospinal fluid coupling is associated with non-motor features of Lewy body disease
- Pregnancy-Associated Vulval Lymphangiectasia With a Non-Vesicular Wart-Like Appearance
BibTeX
@misc{halabi2026effect,
title = {{Effect of Vesicular Monoamine Transporter Type-2 Inhibitors on Motor Features in HD}},
author = {N. M. Halabi and P. C. Nopoulos and A. Killoran},
howpublished = {medRxiv},
year = {2026},
month = sep,
doi = {10.64898/2026.09.26.26364085},
url = {https://www.medrxiv.org/content/10.64898/2026.09.26.26364085v1},
}
RIS
TY - UNPB
TI - Effect of Vesicular Monoamine Transporter Type-2 Inhibitors on Motor Features in HD
AU - N. M. Halabi
AU - P. C. Nopoulos
AU - A. Killoran
PY - 2026
DA - 2026/09/26
PB - medRxiv
DO - 10.64898/2026.09.26.26364085
UR - https://www.medrxiv.org/content/10.64898/2026.09.26.26364085v1
ER -